Regulation of immune cell function and differentiation by the NKG2D receptor

Cellular and Molecular Life Sciences

Volumn 68, Issue 21, 2011, Pages 3519-3529

  Zafirova, Biljana ^a   Wensveen, Felix M ^a   Gulin, Maja ^a   Polić, Bojan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Autoimmunity; NK cell development; NKG2D; NKG2D ligands; Tumors; Viruses

Indexed keywords

ANTIBODY; FAS LIGAND; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; JANUS KINASE 3; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICA ANTIBODY; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; STAT5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VAV PROTEIN;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNITY; BACTERIAL IMMUNITY; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DNA DAMAGE; DRUG EFFICACY; ECTROMELIA VIRUS; EPSTEIN BARR VIRUS; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LISTERIA MONOCYTOGENES; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; HUMANS; KILLER CELLS, NATURAL; MICE; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; VIRUS DISEASES;

MUS;

EID: 80054717670     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0797-0     Document Type: Review

References (139)

1. S Bauer V Groh J Wu A Steinle JH Phillips LL Lanier T Spies 1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 727 729 10426993 1:CAS:528:DyaK1MXltVehsro%3D 10.1126/science.285.5428.727 (Pubitemid 29484539)
2. DH Raulet 2003 Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 781 790 14523385 1:CAS:528:DC%2BD3sXoslSgsb0%3D 10.1038/nri1199 (Pubitemid 37328656)
3. + T cells specific for human cytomegalovirus Eur J Immunol 36 3198 3206 17109473 1:CAS:528: DC%2BD28XhtlCnsr%2FE 10.1002/eji.200636682 (Pubitemid 44932721)
4. + T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions Gastroenterology 132 2346 2358 17570210 1:CAS:528:DC%2BD2sXnvFOhtLc%3D 10.1053/j.gastro.2007.03. 025 (Pubitemid 46890855)
5. V Groh A Bruhl H El-Gabalawy JL Nelson T Spies 2003 Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis Proc Natl Acad Sci USA 100 9452 9457 12878725 1:CAS:528:DC%2BD3sXmtlykur4%3D 10.1073/pnas.1632807100 (Pubitemid 37033949)
6. V Groh K Smythe Z Dai T Spies 2006 Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity Nat Immunol 7 755 762 16732291 1:CAS:528:DC%2BD28XlvFGjsb4%3D 10.1038/ni1350 (Pubitemid 43905875)
7. J Bartkova Z Horejsi K Koed A Kramer F Tort K Zieger P Guldberg M Sehested JM Nesland C Lukas T Orntoft J Lukas J Bartek 2005 DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 434 864 870 15829956 1:CAS:528:DC%2BD2MXjtFOms7k%3D 10.1038/nature03482 (Pubitemid 40558993)
8. VG Gorgoulis LV Vassiliou P Karakaidos P Zacharatos A Kotsinas T Liloglou M Venere RA Ditullio Jr NG Kastrinakis B Levy D Kletsas A Yoneta M Herlyn C Kittas TD Halazonetis 2005 Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 434 907 913 15829965 1:CAS:528:DC%2BD2MXjtFOms7Y%3D 10.1038/nature03485 (Pubitemid 40559004)
9. N Guerra YX Tan NT Joncker A Choy F Gallardo N Xiong S Knoblaugh D Cado NM Greenberg DH Raulet 2008 NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy Immunity 28 571 580 18394936 1:CAS:528:DC%2BD1cXkvV2itL8%3D 10.1016/j.immuni.2008.02.016
10. K Ogasawara JA Hamerman LR Ehrlich H Bour-Jordan P Santamaria JA Bluestone LL Lanier 2004 NKG2D blockade prevents autoimmune diabetes in NOD mice Immunity 20 757 767 15189740 1:CAS:528:DC%2BD2cXltlKisbw%3D 10.1016/j.immuni.2004.05.008 (Pubitemid 38757445)
11. K Ogasawara J Benjamin R Takaki JH Phillips LL Lanier 2005 Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts Nat Immunol 6 938 945 16086018 1:CAS:528:DC%2BD2MXos1eqt7g%3D 10.1038/ni1236 (Pubitemid 43090449)
12. D Cosman J Mullberg CL Sutherland W Chin R Armitage W Fanslow M Kubin NJ Chalupny 2001 ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor Immunity 14 123 133 11239445 1:CAS:528:DC%2BD3MXivFOqurw%3D 10.1016/S1074- 7613(01)00095-4 (Pubitemid 32206515)
13. V Groh R Rhinehart J Randolph-Habecker MS Topp SR Riddell T Spies 2001 Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells Nat Immunol 2 255 260 11224526 1:CAS:528: DC%2BD3MXhvVaksr8%3D 10.1038/85321 (Pubitemid 33706003)
14. S Jonjic M Babic B Polic A Krmpotic 2008 Immune evasion of natural killer cells by viruses Curr Opin Immunol 20 30 38 18206359 1:CAS:528: DC%2BD1cXisVWhu7c%3D 10.1016/j.coi.2007.11.002
15. K Wiemann HW Mittrucker U Feger SA Welte WM Yokoyama T Spies HG Rammensee A Steinle 2005 Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo J Immunol 175 720 729 16002667 1:CAS:528:DC%2BD2MXlvFSjsLw%3D (Pubitemid 41094952)
16. N Nausch A Cerwenka 2008 NKG2D ligands in tumor immunity Oncogene 27 5944 5958 18836475 1:CAS:528:DC%2BD1cXhtF2msbbN 10.1038/onc.2008.272
17. EL Ho JW Heusel MG Brown K Matsumoto AA Scalzo WM Yokoyama 1998 Murine NKG2D and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells Proc Natl Acad Sci USA 95 6320 6325 9600963 1:CAS:528:DyaK1cXjtlOju78%3D 10.1073/pnas.95.11.6320 (Pubitemid 28249010)
18. J Glienke Y Sobanov C Brostjan C Steffens C Nguyen H Lehrach E Hofer F Francis 1998 The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex Immunogenetics 48 163 173 9683661 1:CAS:528:DyaK1cXls1ait7c%3D 10.1007/s002510050420 (Pubitemid 28352182)
19. M Champsaur LL Lanier 2010 Effect of NKG2D ligand expression on host immune responses Immunol Rev 235 267 285 20536569 1:CAS:528:DC%2BC3cXnt1Kjt78%3D
20. S Gasser S Orsulic EJ Brown DH Raulet 2005 The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor Nature 436 1186 1190 15995699 1:CAS:528:DC%2BD2MXovVOgtr4%3D 10.1038/nature03884 (Pubitemid 41232299)
21. JP Houchins T Yabe C McSherry FH Bach 1991 DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells J Exp Med 173 1017 1020 2007850 1:CAS:528: DyaK3MXlt1yktLc%3D 10.1084/jem.173.4.1017
22. A Diefenbach E Tomasello M Lucas AM Jamieson JK Hsia E Vivier DH Raulet 2002 Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nat Immunol 3 1142 1149 12426565 1:CAS:528:DC%2BD38XovFChsbY%3D 10.1038/ni858 (Pubitemid 35469698)
23. S Gilfillan EL Ho M Cella WM Yokoyama M Colonna 2002 NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation Nat Immunol 3 1150 1155 12426564 1:CAS:528:DC%2BD38XovFChsbk%3D 10.1038/ni857 (Pubitemid 35469699)
24. D Garrity ME Call J Feng KW Wucherpfennig 2005 The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure Proc Natl Acad Sci USA 102 7641 7646 15894612 1:CAS:528: DC%2BD2MXkslOnu7o%3D 10.1073/pnas.0502439102 (Pubitemid 40741024)
25. DB Rosen M Araki JA Hamerman T Chen T Yamamura LL Lanier 2004 A Structural basis for the association of DAP12 with mouse, but not human, NKG2D J Immunol 173 2470 2478 15294961 1:CAS:528:DC%2BD2cXmt1Oltrs%3D (Pubitemid 39063104)
26. C Chang J Dietrich AG Harpur JA Lindquist A Haude YW Loke A King M Colonna J Trowsdale MJ Wilson 1999 Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties J Immunol 163 4651 4654 10528161 1:CAS:528:DyaK1MXmvFajsLc%3D (Pubitemid 29501224)
27. J Wu Y Song AB Bakker S Bauer T Spies LL Lanier JH Phillips 1999 An activating immunoreceptor complex formed by NKG2D and DAP10 Science (New York) 285 730 732 1:CAS:528:DyaK1MXltVehsrc%3D 10.1126/science.285.5428.730 (Pubitemid 29484540)
28. J Wu H Cherwinski T Spies JH Phillips LL Lanier 2000 DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells J Exp Med 192 1059 1068 11015446 1:CAS:528:DC%2BD3cXntFSlt7k%3D 10.1084/jem.192.7.1059
29. LL Lanier BC Corliss J Wu C Leong JH Phillips 1998 Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells Nature 391 703 707 9490415 1:CAS:528:DyaK1cXht1Knuro%3D 10.1038/35642 (Pubitemid 28113218)
30. + T cells and NK cells J Immunol 175 7819 7828 16339517 1:CAS:528: DC%2BD2MXht12jtrbL (Pubitemid 41798342)
31. BJ McFarland T Kortemme SF Yu D Baker RK Strong 2003 Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands Structure 11 411 422 12679019 1:CAS:528:DC%2BD3sXislelurY%3D 10.1016/S0969-2126(03)00047-9 (Pubitemid 36419568)
32. BJ McFarland RK Strong 2003 Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation Immunity 19 803 812 14670298 1:CAS:528:DC%2BD3sXhtVWnsrvF 10.1016/S1074-7613(03) 00320-0 (Pubitemid 37542301)
33. DW Wolan L Teyton MG Rudolph B Villmow S Bauer DH Busch IA Wilson 2001 Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A Nat Immunol 2 248 254 11224525 1:CAS:528:DC%2BD3MXhvValu7g%3D 10.1038/85311 (Pubitemid 33706002)
34. A Cerwenka AB Bakker T McClanahan J Wagner J Wu JH Phillips LL Lanier 2000 Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice Immunity 12 721 727 10894171 1:CAS:528:DC%2BD3cXkslagurw%3D 10.1016/S1074-7613(00)80222-8
35. A Diefenbach AM Jamieson SD Liu N Shastri DH Raulet 2000 Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages Nat Immunol 1 119 126 11248803 1:CAS:528:DC%2BD3cXlsFOmur8%3D 10.1038/77793
36. S Malarkannan PP Shih PA Eden T Horng AR Zuberi G Christianson D Roopenian N Shastri 1998 The molecular and functional characterization of a dominant minor H antigen, H60 J Immunol 161 3501 3509 9759870 1:CAS:528:DyaK1cXmsFWlsLo%3D
37. A Takada S Yoshida M Kajikawa Y Miyatake U Tomaru M Sakai H Chiba K Maenaka D Kohda K Fugo M Kasahara 2008 Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D J Immunol 180 1678 1685 18209064 1:CAS:528:DC%2BD1cXotlKjsw%3D%3D
38. MI Whang N Guerra DH Raulet 2009 Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin J Immunol 182 4557 4564 19342629 1:CAS:528:DC%2BD1MXjvFOjt7o%3D 10.4049/jimmunol.0802439
39. LN Carayannopoulos OV Naidenko DH Fremont WM Yokoyama 2002 Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D J Immunol 169 4079 4083 12370332 1:CAS:528:DC%2BD38XnvFGnt78%3D (Pubitemid 35178173)
40. A Diefenbach JK Hsia MY Hsiung DH Raulet 2003 A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity Eur J Immunol 33 381 391 12645935 1:CAS:528:DC%2BD3sXhtlOktLc%3D 10.1002/immu.200310012 (Pubitemid 36267602)
41. L Bacon RA Eagle M Meyer N Easom NT Young J Trowsdale 2004 Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D J Immunol 173 1078 1084 15240696 1:CAS:528:DC%2BD2cXlsVGisrg%3D (Pubitemid 38924282)
42. M Radosavljevic B Cuillerier MJ Wilson O Clement S Wicker S Gilfillan S Beck J Trowsdale S Bahram 2002 A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3 Genomics 79 114 123 11827464 1:CAS:528:DC%2BD38XpsVSnsA%3D%3D 10.1006/geno.2001.6673
43. A Steinle P Li DL Morris V Groh LL Lanier RK Strong T Spies 2001 Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family Immunogenetics 53 279 287 11491531 1:CAS:528:DC%2BD3MXkvVWlurY%3D 10.1007/s002510100325 (Pubitemid 32678762)
44. V Groh S Bahram S Bauer A Herman M Beauchamp T Spies 1996 Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proc Natl Acad Sci USA 93 12445 12450 8901601 1:CAS:528:DyaK28Xms1Gisrw%3D 10.1073/pnas.93.22.12445 (Pubitemid 26367163)
45. TJ Nice L Coscoy DH Raulet 2009 Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress J Exp Med 206 287 298 19171762 1:CAS:528:DC%2BD1MXit1KjtbY%3D 10.1084/jem.20081335
46. M Fang LL Lanier LJ Sigal 2008 A role for NKG2D in NK cell-mediated resistance to poxvirus disease PLoS Pathog 4 e30 18266471 10.1371/journal.ppat. 0040030 1:CAS:528:DC%2BD1cXksFels7g%3D (Pubitemid 351340717)
47. + T cells: evidence for a protective role in virus-induced encephalitis J Virol 82 3031 3044 18160433 1:CAS:528:DC%2BD1cXjtVarurs%3D 10.1128/JVI.02033-07 (Pubitemid 351329191)
48. J Ward M Bonaparte J Sacks J Guterman M Fogli D Mavilio E Barker 2007 HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts Blood 110 1207 1214 17513617 1:CAS:528:DC%2BD2sXptFKlsrw%3D 10.1182/blood-2006-06-028175 (Pubitemid 47281418)
49. M Draghi A Pashine B Sanjanwala K Gendzekhadze C Cantoni D Cosman A Moretta NM Valiante P Parham 2007 NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection J Immunol 178 2688 2698 17312110 1:CAS:528: DC%2BD2sXhvFSisr8%3D (Pubitemid 46333145)
50. Y Chen H Wei R Sun Z Dong J Zhang Z Tian 2007 Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells Hepatology 46 706 715 17626270 1:CAS:528:DC%2BD2sXhtFWhsr3N 10.1002/hep.21872 (Pubitemid 47436116)
51. C Dunn NJ Chalupny CL Sutherland S Dosch PV Sivakumar DC Johnson D Cosman 2003 Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity J Exp Med 197 1427 1439 12782710 1:CAS:528:DC%2BD3sXksVOit78%3D 10.1084/jem.20022059 (Pubitemid 36682542)
52. SA Welte C Sinzger SZ Lutz H Singh-Jasuja KL Sampaio U Eknigk HG Rammensee A Steinle 2003 Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein Eur J Immunol 33 194 203 12594848 1:CAS:528:DC%2BD3sXos1Sltg%3D%3D 10.1002/immu.200390022 (Pubitemid 36157657)
53. NJ Bennett O Ashiru FJ Morgan Y Pang G Okecha RA Eagle J Trowsdale JG Sissons MR Wills 2010 Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus J Immunol 185 1093 1102 20530255 1:CAS:528: DC%2BC3cXotlymtL8%3D 10.4049/jimmunol.1000789
54. NJ Chalupny A Rein-Weston S Dosch D Cosman 2006 Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142 Biochem Biophys Res Commun 346 175 181 16750166 1:CAS:528:DC%2BD28Xls1GmsbY%3D 10.1016/j.bbrc.2006.05.092 (Pubitemid 43865981)
55. O Ashiru NJ Bennett LH Boyle M Thomas J Trowsdale MR Wills 2009 NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142 J Virol 83 12345 12354 19793804 1:CAS:528:DC%2BD1MXhsVyrtLnM 10.1128/JVI.01175-09
56. Y Zhang AM Lazaro B Lavingia P Stastny 2001 Typing for all known MICA alleles by group-specific PCR and SSOP Hum Immunol 62 620 631 11390037 1:CAS:528:DC%2BD3MXktVKks7c%3D 10.1016/S0198-8859(01)00241-5 (Pubitemid 32506180)
57. GM Venkataraman D Suciu V Groh JM Boss T Spies 2007 Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D J Immunol 178 961 969 17202358 1:CAS:528:DC%2BD2sXhvVaiuw%3D%3D (Pubitemid 46095169)
58. N Stern-Ginossar C Gur M Biton E Horwitz M Elboim N Stanietsky M Mandelboim O Mandelboim 2008 Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D Nat Immunol 9 1065 1073 18677316 1:CAS:528:DC%2BD1cXhtVSis7fL 10.1038/ni.1642
59. N Stern-Ginossar N Elefant A Zimmermann DG Wolf N Saleh M Biton E Horwitz Z Prokocimer M Prichard G Hahn D Goldman-Wohl C Greenfield S Yagel H Hengel Y Altuvia H Margalit O Mandelboim 2007 Host immune system gene targeting by a viral miRNA Science 317 376 381 17641203 1:CAS:528:DC%2BD2sXnslGrs7o%3D 10.1126/science.1140956 (Pubitemid 47106378)
60. A Krmpotic M Hasan A Loewendorf T Saulig A Halenius T Lenac B Polic I Bubic A Kriegeskorte E Pernjak-Pugel M Messerle H Hengel DH Busch UH Koszinowski S Jonjic 2005 NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 J Exp Med 201 211 220 15642742 1:CAS:528:DC%2BD2MXot12mtg%3D%3D 10.1084/jem.20041617 (Pubitemid 40189430)
61. M Lodoen K Ogasawara JA Hamerman H Arase JP Houchins ES Mocarski LL Lanier 2003 NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules J Exp Med 197 1245 1253 12756263 1:CAS:528: DC%2BD3sXktVGgtb4%3D 10.1084/jem.20021973 (Pubitemid 36617771)
62. + T cells and NK cells in vivo Nat Immunol 3 529 535 12021778 1:CAS:528:DC%2BD38XjvFOmsbc%3D 10.1038/ni799 (Pubitemid 34662304)
63. M Hasan A Krmpotic Z Ruzsics I Bubic T Lenac A Halenius A Loewendorf M Messerle H Hengel S Jonjic UH Koszinowski 2005 Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein J Virol 79 2920 2930 15709011 1:CAS:528:DC%2BD2MXitlaqu7g%3D 10.1128/JVI.79.5.2920-2930.2005 (Pubitemid 40270570)
64. T Lenac M Budt J Arapovic M Hasan A Zimmermann H Simic A Krmpotic M Messerle Z Ruzsics UH Koszinowski H Hengel S Jonjic 2006 The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60 J Exp Med 203 1843 1850 16831899 1:CAS:528:DC%2BD28Xotleis7s%3D 10.1084/jem.20060514 (Pubitemid 44188458)
65. J Arapovic T Lenac Rovis AB Reddy A Krmpotic S Jonjic 2009 Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60 Mol Immunol 47 114 122 19297023 1:CAS:528:DC%2BD1MXhtleksb3N 10.1016/j.molimm.2009.02.010
66. M Thomas JM Boname S Field S Nejentsev M Salio V Cerundolo M Wills PJ Lehner 2008 Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity Proc Natl Acad Sci USA 105 1656 1661 18230726 1:CAS:528:DC%2BD1cXhvFajs70%3D 10.1073/pnas.0707883105 (Pubitemid 351346570)
67. IY Pappworth EC Wang M Rowe 2007 The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing J Virol 81 474 482 17079298 1:CAS:528:DC%2BD2sXms1Siug%3D%3D 10.1128/JVI.01777-06 (Pubitemid 46067874)
68. RO Jacoby PN Bhatt DG Brownstein 1989 Evidence that NK cells and interferon are required for genetic resistance to lethal infection with Ectromelia virus Arch Virol 108 49 58 2480764 1:STN:280:DyaK3c%2FovVWhuw%3D%3D 10.1007/BF01313742 (Pubitemid 20055714)
69. JA Campbell DS Trossman WM Yokoyama LN Carayannopoulos 2007 Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D J Exp Med 204 1311 1317 17548517 1:CAS:528:DC%2BD2sXms1akt7w%3D 10.1084/jem.20062026 (Pubitemid 46919869)
70. C Cerboni F Neri N Casartelli A Zingoni D Cosman P Rossi A Santoni M Doria 2007 Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity J Gen Virol 88 242 250 17170457 1:CAS:528:DC%2BD2sXmslelsQ%3D%3D 10.1099/vir.0.82125-0 (Pubitemid 46085135)
71. GB Cohen RT Gandhi DM Davis O Mandelboim BK Chen JL Strominger D Baltimore 1999 The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10 661 671 10403641 1:CAS:528:DyaK1MXksVSmsLk%3D 10.1016/S1074-7613(00)80065-5 (Pubitemid 29302919)
72. J Richard S Sindhu TN Pham JP Belzile EA Cohen 2010 HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing Blood 115 1354 1363 20008788 1:CAS:528:DC%2BC3cXjtVWrurg%3D 10.1182/blood-2009-08-237370
73. LL Lanier 2001 A renaissance for the tumor immunosurveillance hypothesis Nat Med 7 1178 1180 11689875 1:CAS:528:DC%2BD3MXotlKltrs%3D 10.1038/nm1101-1178 (Pubitemid 33063762)
74. A Cerwenka JL Baron LL Lanier 2001 Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo Proc Natl Acad Sci USA 98 11521 11526 11562472 1:CAS:528:DC%2BD3MXnt12jsrw%3D 10.1073/pnas.201238598 (Pubitemid 32928761)
75. A Diefenbach ER Jensen AM Jamieson DH Raulet 2001 Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 413 165 171 11557981 1:CAS:528:DC%2BD3MXntVOqtrk%3D 10.1038/35093109 (Pubitemid 32867877)
76. V Groh R Rhinehart H Secrist S Bauer KH Grabstein T Spies 1999 Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proc Natl Acad Sci USA 96 6879 6884 10359807 1:CAS:528:DyaK1MXks1Wktro%3D 10.1073/pnas.96.12.6879 (Pubitemid 29274978)
77. P Gourzi T Leonova FN Papavasiliou 2006 A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus Immunity 24 779 786 16782033 1:CAS:528:DC%2BD28Xms1CrtL0%3D 10.1016/j.immuni. 2006.03.021 (Pubitemid 43867362)
78. A Soriani A Zingoni C Cerboni ML Iannitto MR Ricciardi V Di Gialleonardo M Cippitelli C Fionda MT Petrucci A Guarini R Foa A Santoni 2009 ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype Blood 113 3503 3511 19098271 1:CAS:528:DC%2BD1MXkslCku7o%3D 10.1182/blood-2008-08-173914
79. V Groh A Steinle S Bauer T Spies 1998 Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells Science 279 1737 1740 9497295 1:CAS:528:DyaK1cXhvVers78%3D 10.1126/science.279.5357.1737 (Pubitemid 28164472)
80. S Basu PA Pioli J Conejo-Garcia CR Wira CL Sentman 2008 Estradiol regulates MICA expression in human endometrial cells Clin Immunol 129 325 332 18728002 1:CAS:528:DC%2BD1cXht1Kgt7vI 10.1016/j.clim.2008.07.005
81. S Negrini VG Gorgoulis TD Halazonetis 2010 Genomic instability-an evolving hallmark of cancer Nat Rev Mol Cell Biol 11 220 228 20177397 1:CAS:528:DC%2BC3cXitlaisb4%3D 10.1038/nrm2858
82. C Dai L Whitesell AB Rogers S Lindquist 2007 Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis Cell 130 1005 1018 17889646 1:CAS:528:DC%2BD2sXhtFKnurvP 10.1016/j.cell.2007.07.020 (Pubitemid 47410269)
83. I Persson 2000 Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings J Steroid Biochem Mol Biol 74 357 364 11162945 1:CAS:528:DC%2BD3MXitFyisw%3D%3D 10.1016/S0960-0760(00)00113-8 (Pubitemid 32126247)
84. LL Molinero MB Fuertes GA Rabinovich L Fainboim NW Zwirner 2002 Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28 J Leukoc Biol 71 791 797 11994503 1:CAS:528:DC%2BD38Xjs12rsr8%3D
85. RW McGilvray RA Eagle NF Watson A Al-Attar G Ball I Jafferji J Trowsdale LG Durrant 2009 NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting Clin Cancer Res 15 6993 7002 19861434 1:CAS:528:DC%2BD1MXhtl2ktLnN 10.1158/1078-0432.CCR-09-0991
86. L Raffaghello I Prigione I Airoldi M Camoriano I Levreri C Gambini D Pende A Steinle S Ferrone V Pistoia 2004 Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma Neoplasia 6 558 568 15548365 1:CAS:528:DC%2BD2cXhtVShurfE 10.1593/neo.04316 (Pubitemid 39411093)
87. C Sers R Kuner CS Falk P Lund H Sueltmann M Braun A Buness M Ruschhaupt J Conrad S Mang-Fatehi I Stelniec U Krapfenbauer A Poustka R Schafer 2009 Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells Int J Cancer 125 1626 1639 19569244 1:CAS:528:DC%2BD1MXpsVKmt74%3D 10.1002/ijc.24557
88. G Eisele J Wischhusen M Mittelbronn R Meyermann I Waldhauer A Steinle M Weller MA Friese 2006 TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells Brain 129 2416 2425 16891318 10.1093/brain/awl205 (Pubitemid 44522126)
89. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner J Exp Med 202 1075 1085 16230475 1:CAS:528:DC%2BD2MXhtFelu7rL 10.1084/jem.20051511 (Pubitemid 41464501)
90. H Li Y Han Q Guo M Zhang X Cao 2009 Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1 J Immunol 182 240 249 19109155 1:CAS:528:DC%2BD1cXhsFCis7bI
91. JC Lee KM Lee DW Kim DS Heo 2004 Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients J Immunol 172 7335 7340 15187109 1:CAS:528:DC%2BD2cXks1ahtbw%3D (Pubitemid 38747593)
92. BK Kaiser D Yim IT Chow S Gonzalez Z Dai HH Mann RK Strong V Groh T Spies 2007 Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands Nature 447 482 486 17495932 1:CAS:528:DC%2BD2sXlsFOhu7g%3D 10.1038/nature05768 (Pubitemid 46816733)
93. HR Salih HG Rammensee A Steinle 2002 Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding J Immunol 169 4098 4102 12370336 1:CAS:528:DC%2BD38XnvFGnt7s%3D (Pubitemid 35178177)
94. RW McGilvray RA Eagle P Rolland I Jafferji J Trowsdale LG Durrant 2010 ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients Int J Cancer 127 1412 1420 20054857 1:CAS:528: DC%2BC3cXpt1Ohsbk%3D 10.1002/ijc.25156
95. DE Oppenheim SJ Roberts SL Clarke R Filler JM Lewis RE Tigelaar M Girardi AC Hayday 2005 Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance Nat Immunol 6 928 937 16116470 1:CAS:528:DC%2BD2MXos1eqtL0%3D 10.1038/ni1239 (Pubitemid 43090448)
96. M Champsaur JN Beilke K Ogasawara UH Koszinowski S Jonjic LL Lanier 2010 Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1 J Immunol 185 157 165 20530257 1:CAS:528:DC%2BC3cXns1Cru74%3D 10.4049/jimmunol.1000397
97. + T cells. PLoS One 5
98. MJ Smyth J Swann E Cretney N Zerafa WM Yokoyama Y Hayakawa 2005 NKG2D function protects the host from tumor initiation J Exp Med 202 583 588 16129707 1:CAS:528:DC%2BD2MXhtVSjs7%2FF 10.1084/jem.20050994 (Pubitemid 41248410)
99. + T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus J Exp Med 206 793 805 19289577 1:CAS:528: DC%2BD1MXkvVSiurY%3D 10.1084/jem.20081648
100. V Groh J Wu C Yee T Spies 2002 Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation Nature 419 734 738 12384702 1:CAS:528:DC%2BD38XnvVyrt7o%3D 10.1038/nature01112 (Pubitemid 35177960)
101. I Waldhauer A Steinle 2006 Proteolytic release of soluble UL16-binding protein 2 from tumor cells Cancer Res 66 2520 2526 16510567 1:CAS:528: DC%2BD28XhvV2ht7Y%3D 10.1158/0008-5472.CAN-05-2520
102. P Boutet S Aguera-Gonzalez S Atkinson CJ Pennington DR Edwards G Murphy HT Reyburn M Vales-Gomez 2009 Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein J Immunol 182 49 53 19109134 1:CAS:528:DC%2BD1cXhsFCisL%2FK
103. W Cao X Xi Z Hao W Li Y Kong L Cui C Ma D Ba W He 2007 RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity J Biol Chem 282 18922 18928 17470428 1:CAS:528:DC%2BD2sXmvVarsbk%3D 10.1074/jbc.M702504200 (Pubitemid 47100170)
104. O Ashiru P Boutet L Fernandez-Messina S Aguera-Gonzalez JN Skepper M Vales-Gomez HT Reyburn 2010 Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA008 that is shed by tumor cells in exosomes Cancer Res 70 481 489 20068167 1:CAS:528:DC%2BC3cXltlWktQ%3D%3D 10.1158/0008-5472.CAN-09-1688
105. A Clayton JP Mitchell J Court S Linnane MD Mason Z Tabi 2008 Human tumor-derived exosomes down-modulate NKG2D expression J Immunol 180 7249 7258 18490724 1:CAS:528:DC%2BD1cXmtVantbo%3D
106. N Fodil L Laloux V Wanner P Pellet G Hauptmann N Mizuki H Inoko T Spies I Theodorou S Bahram 1996 Allelic repertoire of the human MHC class I MICA gene Immunogenetics 44 351 357 8781120 1:CAS:528:DyaK28XmsFCmsLs%3D 10.1007/BF02602779 (Pubitemid 26293848)
107. A Jumnainsong AV Romphruk P Jearanaikoon K Klumkrathok A Romphruk S Luanrattanakorn C Leelayuwat 2007 Association of polymorphic extracellular domains of MICA with cervical cancer in northeastern Thai population Tissue Antigens 69 326 333 17389016 1:CAS:528:DC%2BD2sXlsVOjtbk%3D 10.1111/j.1399-0039. 2006.00754.x (Pubitemid 46481063)
108. J Reinders EH Rozemuller HG Otten LT van der Veken PJ Slootweg MG Tilanus 2007 HLA and MICA associations with head and neck squamous cell carcinoma Oral Oncol 43 232 240 16857416 1:CAS:528:DC%2BD2sXhvVyrsrY%3D 10.1016/j.oraloncology. 2006.03.003 (Pubitemid 46228007)
109. S Tamaki N Sanefuzi K Ohgi Y Imai M Kawakami K Yamamoto A Ishitani K Hatake T Kirita 2007 An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients J Oral Pathol Med 36 351 356 17559497 1:CAS:528:DC%2BD2sXosVakt74%3D 10.1111/j.1600-0714.2007.00539.x (Pubitemid 46889875)
110. H Nuckel M Switala L Sellmann PA Horn J Durig U Duhrsen R Kuppers H Grosse-Wilde V Rebmann 2010 The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia Leukemia 24 1152 1159 20428196 1:CAS:528:DC%2BC3cXntFShsrc%3D 10.1038/leu.2010.74
111. TJ Nice W Deng L Coscoy DH Raulet 2010 Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase J Immunol 185 5369 5376 20870941 1:CAS:528:DC%2BC3cXhtlWhsrbM 10.4049/jimmunol.1000247
112. M Vales-Gomez SE Chisholm RL Cassady-Cain P Roda-Navarro HT Reyburn 2008 Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors Cancer Res 68 1546 1554 18316620 1:CAS:528: DC%2BD1cXislansrw%3D 10.1158/0008-5472.CAN-07-2973 (Pubitemid 351346864)
113. S Diermayr H Himmelreich B Durovic A Mathys-Schneeberger U Siegler U Langenkamp J Hofsteenge A Gratwohl A Tichelli M Paluszewska W Wiktor-Jedrzejczak CP Kalberer A Wodnar-Filipowicz 2008 NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities Blood 111 1428 1436 17993609 1:CAS:528:DC%2BD1cXhvFejtbY%3D 10.1182/blood-2007-07-101311 (Pubitemid 351213430)
114. M Jinushi FS Hodi G Dranoff 2006 Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity Proc Natl Acad Sci USA 103 9190 9195 16754847 1:CAS:528: DC%2BD28XmsVWjtr4%3D 10.1073/pnas.0603503103 (Pubitemid 43902554)
115. C Germain E Campigna I Salhi S Morisseau I Navarro-Teulon JP Mach A Pelegrin B Robert 2008 Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein Protein Eng Des Sel 21 665 672 18790793 1:CAS:528:DC%2BD1cXht1Khu7fE 10.1093/protein/gzn047
116. EP von Strandmann HP Hansen KS Reiners R Schnell P Borchmann S Merkert VR Simhadri A Draube M Reiser I Purr M Hallek A Engert 2006 A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo Blood 107 1955 1962 10.1182/blood-2005-05- 2177 1:CAS:528:DC%2BD28XitFChtrk%3D (Pubitemid 43289377)
117. S Caillat-Zucman 2006 How NKG2D ligands trigger autoimmunity? Hum Immunol 67 204 207 16698443 1:CAS:528:DC%2BD28Xks1elt7c%3D 10.1016/j.humimm.2006.02.013 (Pubitemid 43673924)
118. L Nikitina-Zake R Rajalingham I Rumba CB Sanjeevi 2004 Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls Ann N Y Acad Sci 1037 161 169 15699512 1:CAS:528:DC%2BD2MXislWhs7c%3D 10.1196/annals.1337.027 (Pubitemid 40299761)
119. JR Bilbao A Martin-Pagola JC Vitoria P Zubillaga L Ortiz L Castano 2002 HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease Tissue Antigens 60 71 76 12366785 1:CAS:528:DC%2BD38XoslSktLY%3D 10.1034/j.1399-0039.2002.600109.x (Pubitemid 35177026)
120. TL Delovitch B Singh 1997 The nonobese diabetic mouse as a model of
121. K Ogasawara JA Hamerman H Hsin S Chikuma H Bour-Jordan T Chen T Pertel C Carnaud JA Bluestone LL Lanier 2003 Impairment of NK cell function by NKG2D modulation in NOD mice Immunity 18 41 51 12530974 1:CAS:528: DC%2BD3sXnvVyrsQ%3D%3D 10.1016/S1074-7613(02)00505-8 (Pubitemid 36120686)
122. TL Van Belle MG von Herrath 2009 The role of the activating receptor NKG2D in autoimmunity Mol Immunol 47 8 11 19286259 10.1016/j.molimm.2009.02.023 1:CAS:528:DC%2BD1MXhtleksbrK
123. D Stepniak F Koning 2006 Celiac disease-sandwiched between innate and adaptive immunity Hum Immunol 67 460 468 16728270 1:CAS:528:DC%2BD28XkvVOms70%3D 10.1016/j.humimm.2006.03.011 (Pubitemid 43765609)
124. + intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease J Clin Invest 118 281 293 18064301 1:CAS:528: DC%2BD1cXksFOktw%3D%3D 10.1172/JCI30989
125. JJ Mention M Ben Ahmed B Begue U Barbe V Verkarre V Asnafi JF Colombel PH Cugnenc FM Ruemmele E McIntyre N Brousse C Cellier N Cerf-Bensussan 2003 Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease Gastroenterology 125 730 745 12949719 1:CAS:528:DC%2BD3sXnvVSiurg%3D 10.1016/S0016-5085(03)01047-3 (Pubitemid 37070691)
126. B Meresse Z Chen C Ciszewski M Tretiakova G Bhagat TN Krausz DH Raulet LL Lanier V Groh T Spies EC Ebert PH Green B Jabri 2004 Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease Immunity 21 357 366 15357947 1:CAS:528:DC%2BD2cXotFakt7c%3D 10.1016/j.immuni.2004.06.020 (Pubitemid 39208337)
127. ND Huntington CA Vosshenrich JP Di Santo 2007 Developmental pathways that generate natural-killer-cell diversity in mice and humans Nat Rev 7 703 714 1:CAS:528:DC%2BD2sXpsV2qtb8%3D 10.1038/nri2154 (Pubitemid 47327395)
128. WM Yokoyama S Kim AR French 2004 The dynamic life of natural killer cells Annu Rev Immunol 22 405 429 15032583 1:CAS:528:DC%2BD2cXktlOgs7c%3D 10.1146/annurev.immunol.22.012703.104711 (Pubitemid 38680428)
129. T Horng JS Bezbradica R Medzhitov 2007 NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway Nat Immunol 8 1345 1352 17952078 1:CAS:528:DC%2BD2sXhtlajtr%2FJ 10.1038/ni1524 (Pubitemid 350138973)
130. JP DiSanto W Muller D Guy-Grand A Fischer K Rajewsky 1995 Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain Proc Natl Acad Sci USA 92 377 381 7831294 1:CAS:528:DyaK2MXjt12qsL0%3D 10.1073/pnas.92.2.377
131. ND Huntington H Puthalakath P Gunn E Naik EM Michalak MJ Smyth H Tabarias MA Degli-Esposti G Dewson SN Willis N Motoyama DC Huang SL Nutt DM Tarlinton A Strasser 2007 Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1 Nat Immunol 8 856 863 17618288 1:CAS:528:DC%2BD2sXnvFejsbo%3D 10.1038/ni1487 (Pubitemid 47103041)
132. MK Kennedy M Glaccum SN Brown EA Butz JL Viney M Embers N Matsuki K Charrier L Sedger CR Willis K Brasel PJ Morrissey K Stocking JC Schuh S Joyce JJ Peschon 2000 Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice J Exp Med 191 771 780 10704459 1:CAS:528:DC%2BD3cXhslygtrc%3D 10.1084/jem.191.5.771
133. JP Di Santo 2006 Natural killer cell developmental pathways: a question of balance Annu Rev Immunol 24 257 286 16551250 1:CAS:528:DC%2BD28XkvFSqt7k%3D 10.1146/annurev.immunol.24.021605.090700
134. H Suzuki GS Duncan H Takimoto TW Mak 1997 Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain J Exp Med 185 499 505 9053450 1:CAS:528:DyaK2sXhtFWnu78%3D 10.1084/jem.185.3.499 (Pubitemid 27078368)
135. JP Lodolce DL Boone S Chai RE Swain T Dassopoulos S Trettin A Ma 1998 IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation Immunity 9 669 676 9846488 1:CAS:528:DyaK1cXnvFWktLY%3D 10.1016/S1074-7613(00)80664-0 (Pubitemid 28557595)
136. T Nosaka JM van Deursen RA Tripp WE Thierfelder BA Witthuhn AP McMickle PC Doherty GC Grosveld JN Ihle 1995 Defective lymphoid development in mice lacking Jak3 Science 270 800 802 7481769 1:CAS:528:DyaK2MXptV2isr0%3D 10.1126/science.270.5237.800
137. K Jiang B Zhong DL Gilvary BC Corliss E Vivier E Hong-Geller S Wei JY Djeu 2002 Syk regulation of phosphoinositide 3-kinase-dependent NK cell function J Immunol 168 3155 3164 11907067 1:CAS:528:DC%2BD38Xis1ajs7c%3D (Pubitemid 34250374)
138. K Jiang B Zhong C Ritchey DL Gilvary E Hong-Geller S Wei JY Djeu 2003 Regulation of Akt-dependent cell survival by Syk and Rac Blood 101 236 244 12393431 1:CAS:528:DC%2BD3sXhtFWiug%3D%3D 10.1182/blood-2002-04-1251 (Pubitemid 36025913)
139. B Zafirova S Mandaric R Antulov A Krmpotic H Jonsson WM Yokoyama S Jonjic B Polic 2009 Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice Immunity 31 270 282 19631564 1:CAS:528:DC%2BD1MXhtFOgsL7E 10.1016/j.immuni.2009.06.017